| Drug Name |
Megestrol |
| Drug ID |
BADD_D01371 |
| Description |
17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. |
| Indications and Usage |
For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used for the palliative management of recurrent, inoperable, or metastatic breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries. |
| Marketing Status |
Not Available |
| ATC Code |
G03AC05; G03DB02; L02AB01 |
| DrugBank ID |
DB00351
|
| KEGG ID |
D08167
|
| MeSH ID |
D008535
|
| PubChem ID |
19090
|
| TTD Drug ID |
D04GJN
|
| NDC Product Code |
46439-8722; 68094-250; 0555-0607; 17856-0907; 49884-230; 49884-907; 50383-859; 63629-2220; 63739-549; 64380-158; 66689-020; 81646-120; 51991-313; 77044-5047; 0121-4776; 49884-290; 63629-7631; 71205-943; 0009-5030; 24979-041; 60429-433; 63629-2221; 0555-0606; 43744-363; 51927-1670; 63592-0109; 0904-3571; 49884-289; 63629-2219; 0904-7072; 0121-0945; 60432-126; 64380-159; 68094-361; 72969-102; 55154-5776 |
| Synonyms |
Megestrol | 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione | Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl- |
